NRX Pharmaceuticals Cash Flow Statement (2024-2025) | NRXP

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -6.20M-7.04M-3.02M-2.43M-3.84M-3.73M-4.02M-5.29M
Depreciation and Depletion (Quarter) 0.00M0.00M-0.99M2.00M-3.99M
Share-based Compensation (Quarter) 0.24M0.10M0.10M-0.30M0.01M0.07M0.07M-0.42M
Gains from Sales and Divestitures (Quarter) 0.06M0.03M0.09M
Gains from Investment Securities (Quarter) 0.01M-0.17M0.17M0.05M8.50M5.00M-8.14M
Non-cash Items (Quarter) 0.04M0.36M
Cash from Operations (Quarter) -3.67M-2.56M-2.31M-2.10M-3.48M-4.03M-2.89M-3.71M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.06M
Depreciation & Amortization (CF) (Quarter) 0.00M0.00M0.00M0.00M0.03M0.04M
Change in Working Capital
Change in Receivables (Quarter) -0.04M
Change in Account Payables (Quarter) 2.09M2.12M0.74M-10.17M0.18M-0.68M0.60M0.01M
Change in Accured Expenses (Quarter) -0.05M0.88M-0.94M10.11M-0.34M0.14M-0.21M0.91M
Other Working Capital Changes (Quarter) -0.25M0.90M-0.65M-0.16M-0.03M-0.23M-0.45M
Investing Activities
Acquisitions (Quarter) -0.18M
Cash from Investing Activities (Quarter) -0.25M
Financing Activities
Other financing activities (Quarter) 0.52M0.38M0.35M2.74M
Cash from Financing Activities (Quarter) 0.40M3.14M2.05M1.90M7.58M1.39M9.73M4.58M
Additional items
Change in Cash (Quarter) -3.28M0.58M-0.25M-0.20M4.11M-2.64M4.27M0.61M
Free Cash Flow (Quarter) -3.67M-2.56M-2.31M-2.10M-3.48M-4.03M-2.89M-3.71M
Net Cash Flow (Quarter) -3.28M0.58M-0.25M-0.20M4.11M-2.64M6.83M0.61M